OBJECTIVES: The peripheral muscle pump is key in promoting cardiac filling during exercise, especially in subjects who lack a subpulmonary ventricle (the Fontan circulation). A muscle-wasting syndrome exists in acquired heart failure but has not been assessed in Fontan subjects. We sought to investigate whether adults with the Fontan circulation exhibit reduced skeletal muscle mass and/or metabolic abnormalities. DESIGN AND PATIENTS: Sixteen New York Heart Association Class I/II Fontan adults (30±2 years) underwent cardiopulmonary exercise testing and lean mass quantification with dual x-ray absorptiometry (DXA); eight had calf muscle (31)P magnetic resonance spectroscopy as did eight healthy age-matched and sex-matched controls. DXA results were compared with Australian reference data. SETTING: Single tertiary referral centre. RESULTS: Peak VO2 was 1.9±0.1 L/min (66±3% of predicted values). Skeletal muscle mass assessed by relative appendicular lean mass index was significantly reduced compared with age-matched and sex-matched reference values (Z-score -1.46±0.22, p<0.0001). Low skeletal muscle mass correlated with poorer VO2 max (r=0.67, p=0.004). Overall, skeletal muscle mass T-score (derived from comparison with young normal reference mean) was -1.47±0.21; 4/16 Fontan subjects had sarcopenic range muscle wasting (T-score <-2.0) and 9/16 had less marked, but clinically significant wasting (T-score <-1.0 but ≥-2.0). Muscle aerobic capacity, measured by the rate constant (k) of postexercise phosphocreatine resynthesis, was significantly impaired in Fontan adults versus controls (1.48±0.13 vs 2.40±0.33 min(-1), p=0.02). CONCLUSIONS: Fontan adults have reduced skeletal muscle mass and intrinsic muscle metabolic abnormalities.
OBJECTIVES: The peripheral muscle pump is key in promoting cardiac filling during exercise, especially in subjects who lack a subpulmonary ventricle (the Fontan circulation). A muscle-wasting syndrome exists in acquired heart failure but has not been assessed in Fontan subjects. We sought to investigate whether adults with the Fontan circulation exhibit reduced skeletal muscle mass and/or metabolic abnormalities. DESIGN AND PATIENTS: Sixteen New York Heart Association Class I/II Fontan adults (30±2 years) underwent cardiopulmonary exercise testing and lean mass quantification with dual x-ray absorptiometry (DXA); eight had calf muscle (31)P magnetic resonance spectroscopy as did eight healthy age-matched and sex-matched controls. DXA results were compared with Australian reference data. SETTING: Single tertiary referral centre. RESULTS: Peak VO2 was 1.9±0.1 L/min (66±3% of predicted values). Skeletal muscle mass assessed by relative appendicular lean mass index was significantly reduced compared with age-matched and sex-matched reference values (Z-score -1.46±0.22, p<0.0001). Low skeletal muscle mass correlated with poorer VO2 max (r=0.67, p=0.004). Overall, skeletal muscle mass T-score (derived from comparison with young normal reference mean) was -1.47±0.21; 4/16 Fontan subjects had sarcopenic range muscle wasting (T-score <-2.0) and 9/16 had less marked, but clinically significant wasting (T-score <-1.0 but ≥-2.0). Muscle aerobic capacity, measured by the rate constant (k) of postexercise phosphocreatine resynthesis, was significantly impaired in Fontan adults versus controls (1.48±0.13 vs 2.40±0.33 min(-1), p=0.02). CONCLUSIONS: Fontan adults have reduced skeletal muscle mass and intrinsic muscle metabolic abnormalities.
Authors: Ryan J Butts; Carolyn T Spencer; Lanier Jackson; Martha E Heal; Geoffrey Forbus; Thomas C Hulsey; Andrew M Atz Journal: Pediatr Cardiol Date: 2014-09-02 Impact factor: 1.655
Authors: Alexander R Opotowsky; Fernando R Baraona; Finnian R Mc Causland; Brittani Loukas; Elizabeth Landzberg; Michael J Landzberg; Venkata Sabbisetti; Sushrut S Waikar Journal: Heart Date: 2016-09-26 Impact factor: 5.994
Authors: Catherine M Avitabile; Mary B Leonard; Babette S Zemel; Jill L Brodsky; Dale Lee; Kathryn Dodds; Christina Hayden-Rush; Kevin K Whitehead; Elizabeth Goldmuntz; Stephen M Paridon; Jack Rychik; David J Goldberg Journal: Heart Date: 2014-06-27 Impact factor: 5.994
Authors: Catherine M Avitabile; David J Goldberg; Mary B Leonard; Zhenglun Alan Wei; Elaine Tang; Stephen M Paridon; Ajit P Yoganathan; Mark A Fogel; Kevin K Whitehead Journal: Heart Date: 2017-10-07 Impact factor: 5.994
Authors: Julian Alexander Härtel; Ulrike Herberg; Thomas Jung; Christian Winkler; Johannes Breuer; Nicole Müller Journal: PLoS One Date: 2020-01-30 Impact factor: 3.240
Authors: Derek Tran; Paolo D'Ambrosio; Charlotte E Verrall; Chantal Attard; Julie Briody; Mario D'Souza; Maria Fiatarone Singh; Julian Ayer; Yves d'Udekem; Stephen Twigg; Glen M Davis; David S Celermajer; Rachael Cordina Journal: J Am Heart Assoc Date: 2020-04-15 Impact factor: 5.501
Authors: Julian Alexander Härtel; Nicole Müller; Ulrike Herberg; Johannes Breuer; Daniel Alexander Bizjak; Wilhelm Bloch; Marijke Grau Journal: Front Physiol Date: 2019-11-22 Impact factor: 4.566